帕金森病患者的眼科问题:视觉损害问卷结果
这项观察性横断面多中心研究使用视觉损害帕金森病问卷(VIPD-Q)评估848例帕金森病患者与250名健康对照的眼科症状。结果显示82%的患者报告至少一种眼科症状,显著高于对照的48%,且症状更常干扰日常活动(68% vs 35%)。VIPD-Q有助于筛查帕金森病患者的眼科症状并及时治疗。
要点
- 帕金森病患者眼科症状患病率82%,显著高于对照的48%。
- 患者各领域眼科症状均更多,VIPD-Q总分中位数10 vs 2。
- 68%患者眼科症状干扰日常活动,对照为35%。
核心结论
- 帕金森病患者眼科症状患病率高于对照,且常干扰日常活动。
研究设计与样本
- 观察性横断面多中心研究,纳入848例帕金森病患者和250名健康对照,使用VIPD-Q问卷评估。
主要发现
- 82%(95%CI 80-85)的患者报告至少一种眼科症状,对照为48%(95%CI 42-54),p<0.001。
- 患者VIPD-Q总分中位数10(IQR 13),对照中位数2(IQR 5),p<0.001。
- 68%(95%CI 65-71)的患者眼科症状干扰日常活动,对照为35%(95%CI 29-41),p<0.001。
关键数值与推荐
- VIPD-Q涵盖眼表、眼内、眼动和视神经四个领域。
临床怎么用
- VIPD-Q等筛查问卷有助于识别帕金森病患者的眼科症状,从而及时治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prevalence and clinical effect of ophthalmologic symptoms in patients with Parkinson disease (PD), compared with controls, using a standardized questionnaire. METHODS: In this observational, cross-sectional, multicenter study, 848 patients with PD and 250 healthy controls completed the Visual Impairment in Parkinson's Disease Questionnaire (VIPD-Q). The VIPD-Q addressed 4 domains according to structures: (1) ocular surface; (2) intraocular; (3) oculomotor; and (4) optic nerve. The questionnaire also assessed the effect of ophthalmologic symptoms on daily activities. RESULTS: One or more ophthalmologic symptoms were reported by 82% (95% confidence interval [CI], 80-85) of patients, compared with 48% (95% CI, 42-54) of controls (p < 0.001). Patients with PD experienced more ophthalmologic symptoms across all domains than controls (p < 0.001), as reflected by a higher VIPD-Q total score among patients (median 10 [interquartile range (IQR) 13]) than controls (median 2 [IQR 5]; p < 0.001). Ophthalmologic symptoms interfered with daily activities in 68% (95% CI, 65-71) of patients, compared with 35% (95% CI, 29-41) of controls (p < 0.001). CONCLUSION: Patients with PD have a higher prevalence of ophthalmologic symptoms than controls. Moreover, these frequently interfere with daily activities. A screening questionnaire such as the VIPD-Q may help with identifying ophthalmologic symptoms in PD, thereby enabling more timely treatment.
引用
- Borm CDJM, Visser F, Werkmann M, et al. Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire. Neurology. 2020. PMID: 32161030. doi:10.1212/WNL.0000000000009214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。